CKD Bio Corp. (KRX:063160)
South Korea · Delayed Price · Currency is KRW 13,600
+70 (0.52%)
Last updated: Aug 6, 2026, 2:25 PM KST
CKD Bio Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Revenue Revenue Growth | 159,935 | 156,042 | 142,238 | 124,600 | 137,184 | 124,510 |
Revenue Growth | 3.59% | 9.71% | 14.16% | -9.17% | 10.18% | 9.45% |
Gross Profit Gross Profit Growth | 6,950 | 16,790 | 13,306 | 27,864 | 36,174 | 23,420 |
Operating Income Operating Income Growth | -25,058 | -14,810 | -11,432 | 7,607 | 15,413 | 7,009 |
Net Income Net Income Growth | -23,130 | -16,703 | -6,577 | 6,207 | 12,265 | 7,956 |
Earnings Per Share EPS Growth | -4216.38 | -3044.61 | -1198.81 | 1147.30 | 2277.20 | 1477.21 |
EPS Growth | - | - | - | -49.62% | 54.16% | 12.07% |
Revenue by Segment
| Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Raw Drug Product Division Raw Drug Product Division Growth | 136,839 | 125,090 | 108,206 | 109,153 |
Probiotics Division Probiotics Division Growth | 17,613 | 24,982 | 34,032 | 15,447 |
Botulinum Toxin Division Botulinum Toxin Division Growth | 5,483 | 5,971 | - | - |
Total Total Growth | 159,935 | 156,042 | 142,238 | 124,600 |
| Fiscal Year | Current | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Cash & Investments Cash & Investments Growth | 12,347 | 12,724 | 3,535 | 1,533 | 4,564 | 16,806 |
Total Debt Total Debt Growth | 159,127 | 138,925 | 109,379 | 79,844 | 28,376 | 4,913 |
Net Cash (Debt) Net Cash Growth | -146,780 | -126,201 | -105,844 | -78,311 | -23,812 | 11,893 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -26756.44 | -23004.34 | -19293.66 | -14474.11 | -4421.14 | 2208.19 |
| Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Operating Cash Flow Operating Cash Flow Growth | -16,588 | -3,205 | -5,882 | 4,824 | 16,990 | 15,536 |
Capital Expenditures CapEx Growth | -6,242 | -6,200 | -20,486 | -61,659 | -47,314 | -16,396 |
Free Cash Flow Free Cash Flow Growth | -22,830 | -9,404 | -26,368 | -56,835 | -30,324 | -860.71 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Gross Margin | 4.35% | 10.76% | 9.35% | 22.36% | 26.37% | 18.81% |
Operating Margin | -15.67% | -9.49% | -8.04% | 6.11% | 11.24% | 5.63% |
Pretax Margin | -16.75% | -11.91% | -9.39% | 5.67% | 11.40% | 7.47% |
Profit Margin | -14.46% | -10.70% | -4.62% | 4.98% | 8.94% | 6.39% |
FCF Margin | -14.27% | -6.03% | -18.54% | -45.61% | -22.11% | -0.69% |
| Fiscal Year | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| Period Ending | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Dividend Per Share Dividend Per Share Growth | 100.000 | 200.000 | 190.476 | 190.476 |
Dividend Per Share Growth | -50.00% | 5.00% | 0% | - |
Dividend Yield | 0.24% | 0.25% | 0.65% | 0.98% |
| Fiscal Year | Current | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 6, 2026 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
PE Ratio | - | - | - | 70.61 | 12.95 | 13.38 |
Forward PE | - | 20.10 | 20.10 | 30.19 | 10.95 | - |
PS Ratio | 0.46 | 0.84 | 1.61 | 3.52 | 1.16 | 0.86 |